Description
Tesamorelin is a synthetic version of the body’s natural growth hormone-releasing hormone (GHRH). In clinical medicine, teamorelin is FDA-approved as an injectable for reducing visceral fat in adults with HIV-related lipodystrophy.
$310.00
In research settings, tesamorelin is investigated for:
Our 10 mL Tesamorelin peptide nasal spray contains 20 mg total peptide, releasing a precise 250 mcg amount for research purposes only. Each bottle contains 80 sprays.
Please note that all payments include a 3.99% processing fee set by our international payment processor.
Tesamorelin is a peptide modeled after GHRH, the hormone that signals the pituitary gland to release growth hormone. It’s clinically used only as an injection, not as a nasal spray. In laboratory research, tesamorelin is studied for its effects on activating growth hormone pathways, influencing fat metabolism, and affecting IGF-1 levels.
The nasal form included here is experimental and intended for studying how tesamorelin behaves via the nasal mucosal route. It is not designed for personal or clinical use.
Sequence: Tyr–Ala–Asp–Ala–Ile–Phe–Thr–Asn–Ser–Tyr–Arg–Lys–Leu–Gly–Gln–Leu–Ser–Ala–Arg–Lys–Leu–Leu–Gln–Asp–Ile–Met–Ser–Arg–Gln–Gln–Gly–Glu–Ser–Asn–Gln–Glu–Arg–Gly–Ala–Arg–Ala–Arg–NH₂.
Molecular formula: C221H366N72O67S
Molecular weight: ~5136 g/mol
Form: Synthetic peptide, nasal spray
Other Ingredients: Lab-Grade Distilled Water.
Tesamorelin Nasal Spray is made with high-purity peptide material and undergoes in-house and third-party lab analysis to confirm:
Lab testing ensures that the material provided is consistent, high-quality, and suitable for research purposes.
Here are some highlighted studies related to Tesamorelin. Please keep in mind that while these studies are promising, this compound isn’t approved as a drug or dietary supplement in nasal spray form, meaning its use remains limited to research.
Tesamorelin basically “nudges” your own growth hormone system rather than dumping growth hormone from the outside. That means it binds to the same receptor as natural GHRH in the pituitary, triggers GH release in pulses, and then lets IGF‑1 and normal feedback loops do the rest.
Clinical trials in adults (including people with HIV‑related fat gain and people with type 2 diabetes or abdominal obesity) show that daily tesamorelin injections increase growth hormone secretion in a “natural‑like” pulsatile way [1]
Tesamorelin is best known for helping reduce “deep belly fat” (visceral fat) in people with HIV‑related fat gain, and the research also examines how it alters fat biology and metabolism at a deeper level.
In HIV‑positive adults with significant increases in abdominal fat, daily tesamorelin injections for 6–12 months cut visceral adipose tissue (the fat around organs) by about 15–20% on average compared with placebo [2].
Tesamorelin affects glucose and insulin pathways, but the data so far suggest mostly mild, sometimes temporary changes rather than large swings in blood sugar.
In a 12‑week study in people with type 2 diabetes, daily tesamorelin increased IGF‑1 (indicating activation of the growth hormone system) but did not significantly alter overall insulin response or average blood sugar control (HbA1c) [3].
Fasting glucose bumped up slightly early on at higher doses, but this effect faded by week 12, suggesting a transient shift in how the body handles sugar when tesamorelin is first started [3].
Can’t find what you need? Contact us and our support team will get back to you within 1–2 business days.
All products on Stemcode are intended strictly for laboratory, academic, and scientific research purposes. They are not approved for human or veterinary use.
Due to the sensitive nature of research materials used, all sales are final unless the product arrives damaged or incorrect.
No. Resale or repackaging without authorization is prohibited. Our products are solely for research.
At this moment, we ship only within the United States.
Each product page includes specific storage guidelines (e.g., refrigeration or room temperature).
Tesamorelin is a synthetic version of the body’s natural growth hormone-releasing hormone (GHRH). In clinical medicine, teamorelin is FDA-approved as an injectable for reducing visceral fat in adults with HIV-related lipodystrophy.
| Weight | 0.01875 lbs |
|---|
Reviews
There are no reviews yet.